Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

ATHN 2: Factor Switching Study

ClinicalTrials.gov ID: NCT02546622

Public ClinicalTrials.gov record NCT02546622. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 5:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Longitudinal, Observational Study of Previously Treated Hemophilia Patients Switching Factor Replacement Products

Study identification

NCT ID
NCT02546622
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
American Thrombosis and Hemostasis Network
Network
Enrollment
310 participants

Conditions and interventions

Conditions

Interventions

  • Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 Biological
  • Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 Biological

Biological

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2015
Primary completion
Jun 29, 2020
Completion
Jun 29, 2020
Last update posted
Dec 8, 2021

2015 – 2020

United States locations

U.S. sites
27
U.S. states
22
U.S. cities
26
Facility City State ZIP Site status
University of California San Diego (UCSD) San Diego California 92122
University of Colorado Denver Hemophilia and Thrombosis Center Aurora Colorado 80045
Yale Hemophilia Treatment Center New Haven Connecticut 06520
Children's National Medical Center Washington D.C. District of Columbia 20010
Johns Hopkins All Children's Hospital St. Petersburg Florida 33701
St. Joseph's Children's Hospital Tampa Florida 33607
Children's Healthcare of Atlanta/Emory Atlanta Georgia 30322
Bleeding and Clotting Disorders Institute Peoria Illinois 61615
Indiana Hemophilia and Thrombosis Center (IHTC) Indianapolis Indiana 46260
Louisiana Center for Bleeding and Clotting Disorders New Orleans Louisiana 70112
Maine Hemophilia and Thrombosis Center Scarborough Maine 04074
Johns Hopkins University Medical Center Baltimore Maryland 21205
Boston Hemophilia Center at Children's Hospital of Boston Boston Massachusetts 02115
University of Michigan Hemophilia and Coagulation Disorders Program Ann Arbor Michigan 48109
Michigan State University Center for Bleeding and Clotting Disorders East Lansing Michigan 48823
Children's Mercy Hospital Kansas City Missouri 64108
Dartmouth-Hitchcock Comprehensive Hemophilia and Thrombosis Center Lebanon New Hampshire 03756
Weill Cornell Medicine New York New York 10065
Mary M. Gooley Hemophilia Center Rochester New York 14621
Oregon Health and Science University Portland Oregon 97239
Children's Hospital of Philadelphia (CHOP) Philadelphia Pennsylvania 19104
Pennsylvania Comprehensive Hemophilia and Thrombophilia Program / Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104
The Hemophilia Center of Western Pennsylvania Pittsburgh Pennsylvania 15213
St Jude Children's Research Hospital Memphis Tennessee 38105
UTSW Medical Center at Dallas/Children's Medical Center Dallas Texas 75235
Washington Center for Bleeding Disorders Bloodworks Northwest d/b/a Puget Sound Blood Center Seattle Washington 98104
Blood Center of Wisconsin Milwaukee Wisconsin 53201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02546622, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 8, 2021 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02546622 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →